Akinloye, A.; Oyedeji, T.; Eniayewu, O.; Adeagbo, B.; Bolaji, O.; Rannard, S.; Owen, A.; Olagunju, A.
Atazanavir/Ritonavir Increased Tizoxanide Exposure from Oral Nitazoxanide through Pharmacokinetic Interaction in Healthy Volunteers. Future Pharmacol. 2024, 4, 163-172.
https://doi.org/10.3390/futurepharmacol4010011
AMA Style
Akinloye A, Oyedeji T, Eniayewu O, Adeagbo B, Bolaji O, Rannard S, Owen A, Olagunju A.
Atazanavir/Ritonavir Increased Tizoxanide Exposure from Oral Nitazoxanide through Pharmacokinetic Interaction in Healthy Volunteers. Future Pharmacology. 2024; 4(1):163-172.
https://doi.org/10.3390/futurepharmacol4010011
Chicago/Turabian Style
Akinloye, Abdulafeez, Timothy Oyedeji, Oluwasegun Eniayewu, Babatunde Adeagbo, Oluseye Bolaji, Steve Rannard, Andrew Owen, and Adeniyi Olagunju.
2024. "Atazanavir/Ritonavir Increased Tizoxanide Exposure from Oral Nitazoxanide through Pharmacokinetic Interaction in Healthy Volunteers" Future Pharmacology 4, no. 1: 163-172.
https://doi.org/10.3390/futurepharmacol4010011
APA Style
Akinloye, A., Oyedeji, T., Eniayewu, O., Adeagbo, B., Bolaji, O., Rannard, S., Owen, A., & Olagunju, A.
(2024). Atazanavir/Ritonavir Increased Tizoxanide Exposure from Oral Nitazoxanide through Pharmacokinetic Interaction in Healthy Volunteers. Future Pharmacology, 4(1), 163-172.
https://doi.org/10.3390/futurepharmacol4010011